Machine learning-based individual treatment effect estimation of azithromycin on COPD exacerbations
K. Verstraete (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), M. Staes (Leuven, Belgium), S. Lindberg (Minneapolis, United States), R. Albert (Denver, United States), J. Connett (Minneapolis, United States), M. De Vos (Leuven, Belgium), W. Janssens (Leuven, Belgium)
Source: International Congress 2022 – COPD treatment: new mechanisms and novel insights
Session: COPD treatment: new mechanisms and novel insights
Session type: Oral Presentation
Number: 750
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Verstraete (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), M. Staes (Leuven, Belgium), S. Lindberg (Minneapolis, United States), R. Albert (Denver, United States), J. Connett (Minneapolis, United States), M. De Vos (Leuven, Belgium), W. Janssens (Leuven, Belgium). Machine learning-based individual treatment effect estimation of azithromycin on COPD exacerbations. 750
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|